INTRODUCTION
The cell membrane is the primary barrier between the intra-and extracellular environments, and it plays important roles in cellular activation and proliferation. Cholesterols, the main components of mammalian cellular membranes, are necessary for cell growth and proliferation, and are required for normal cellular activity. Endogenous cholesterol synthesis is regulated by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, while exogenous cholesterol is added to the cell membrane via intake by the lowdensity lipoprotein receptors (LDL-R). Endogenous and exogenous cholesterols interact with each other to maintain a relatively stable cholesterol level within the cell [1] . Indeed, research has shown that cholesterol depletion can lead to phenotypic changes and inhibition of cell growth [2] . Lovastatin (LOV) and other statins, commonly used to lower blood-lipid levels, are inhibitors of HMG-CoA reductase. They can lower endogenous cellular cholesterol synthesis, and block the mevalonate (MVA) metabolic pathway, the end products of which (cholesterols, dolichol, coenzyme Q, isoamylene proteins, etc.) are necessary components of the cell membranes. Consequently, inhibition of the MVA metabolic pathway not only blocks neogenesis of membrane lipids, but also impacts on membrane electron transfer and modifies Ras superfamily members. In addition, LOV was recently assessed as a possible anti-tumor drug that might inhibit tumor cell proliferation, or induce tumor cell differentiation, maturity or apoptosis [3, 4] . Maintenance of normal membrane structure is vital to membrane functions such as ion flow across cellular membranes and intercellular communication. Cellular proliferation and differentiation, demonstrating membrane potential, cytosolic free Ca 2+ concentration ([Ca 2+ ] i ), gap junctional intercellular communication (GJIC) [5] and intracellular signal transmission are all closely related to the structure and function of cellular membranes and the membrane framework. It is therefore important to understand the impact of LOV on the membranes of normal and cancerous cells. In this study, we investigated the molecular mechanism of LOV anti-tumor function through assessments of its effect on the ion flow across membranes, GJIC, and the pathways of related signals in MCF-7 mammary cancer cells.
Expression levels of plasma membrane calcium ATPase mRNA
The level of plasma membrane calcium ATPase 1 (PMCA1) mRNA expression in the MCF-7 cells was analyzed as described previously [10] . Briefly, for reverse transcription, 3 µg of RNA dissolved in 50 µl PCR-compatible buffer was combined with 50 µl of 2×RT Master Mix (10 µl of 10×reverse transcription buffer, 4 µl of 10mmol/L dNTPs, 10 µl of 10×random primers, 5 µl of multiscribe reverse transcriptase (50 U/µl) and 21 µl of nuclease-free H 2 O), and RT was performed at 37ºC for 60 min, and then 72ºC for 10 min. For PCR, 10 ng of cDNA was combined with primers and 2×SYBR Green PCR Master Mix to a final reaction volume of 50 µl. The nucleotide sequences for the different primer pairs were as follows: PMCA1: forward primer 5'-TGGTGCAAATTCCATAGACATCTC-3', reverse primer 5'-GAGCTGCGGGCTCTCATG-3', producing an 88-bp amplification product; Human β-actin: forward primer 5'-GGGTCAGAAGGATTCCTAATG-3', reverse primer 5'-GGTCTCAAACATGATCTGGG-3', amplified as an internal control, and with a PCR product 237 bp long. PCR reactions were done at 95ºC for 5 min, followed by 45 cycles at 94ºC, 20 s, and 62ºC, 1 min. Finally, the RT-PCR products were examined via 1.5% agarose gel electrophoresis to ensure that bands were visible only at the expected molecular weight.
Change in GJIC function
GJIC function changes were examined via the scrape-loading dye transfer method [11] . Briefly, cells were seeded into 35-mm dishes and fed to saturation density. The cells were treated with different doses of LOV for 24-72 h, then rinsed three times with PBS, then exposed to 0.05% Lucifer Yellow CH (Sigma). Scrape lines CELLULAR & MOLECULAR BIOLOGY LETTERS 5 were made with scrape blades. After 3 min, the dishes were rinsed three times with PBS, examined with a Nikon fluorescence microscope and photographed.
Western blot analysis of ERK1 and p38
MAPK protein expression Cytosolic extracts were prepared using ice-cold Nonidet P-40 (NP-40) lysis buffer (50 mmol/L Tris-HCl pH 8.0, 150 mmol/L NaCl, 25 mmol/L NaF, 5 mmol/L Na 4 P 2 O 7 , 0.1% NP-40, 10 µg/ml aprotinin, 10 µg/ml leupetin, 1 mmol/L phenylmethylsulfonyl fluoride) and incubated on ice for 30 min. After centrifugation at 12,000 g for 15 min, the protein in the supernatants was quantitated by the Lowry method using bovine serum albium (BSA) as a standard. Sixty micrograms of protein per lane was electrophoresed on 10% SDSpolyacrylamide gels. After transfer of the protein from the gel to nitrocellulose membranes, the membranes were blocked at 37ºC for 1 h in PBS plus 0.1% Tween-20 (PBS-T) containing 1% BSA, then incubated for 1 h at 37ºC with polyclonal antibodies against human ERK1 or human p38 MAPK antibody. Bound antibody was detected by chemiluminescene.
In vitro kinase assay for ERK and p38
MAPK activities Proteins (200 µg) were incubated for 4 h at 4ºC with ERK1 or p38 MAPK polyclonal antibody (1 µg), then for 2 h at 4ºC with protein A-Sepharose. MAPK kinase assays were performed for 30 min at 25ºC on the bound immune complexes in a reaction buffer containing substrate protein (1mg/ml MBP), 40 µmol/L ATP and 2 µCi [γ- 
Statistical analysis
All the data was analyzed using SPSS software ver. 10.0. All the quantitative data was presented as the mean±standard error of three independent experiments. Statistical significance was assessed using variance analyses.
RESULTS

The effect of LOV on MCF-7 cell growth
The MTT assay showed that after 24-72 hours of treatment with 4-16 µmol/L LOV, the A492 values of the treated group had all declined in a dose-and timedependent manner compared to the controls ( Fig. 1) . From the formula for growth inhibition (GI), we found that GI increased from 5.57 to 42.42% and 17.39 to 75.80% with increasing time after treatment with, respectively, 4 and 16 µmol/L LOV ( Fig. 2 ).
Changes in membrane potential as observed by laser confocal microscopy
The quantity of diS-C 3 -(5) in cells can directly reflect changes in membrane potential: hyperpolarization of cells increases the partitioning of this positivelycharged dye into the lipid phase of the membrane and cytoplasm [6] , where its fluorescene is quenched, while its flourescence intensifies in the opposite case. In Vol. 12. No. 1. 2007 CELL. MOL. BIOL. LETT. 6 this study, after the treatment with 4, 8 or 16 µmol/L LOV, the quantity of diS-C 3 -(5) in MCF-7 cells was observed to gradually decline (Fig. 3) . This illustrated that within the cells, LOV treatment resulted in an increase in the negative value of membrane potential and a change in the cells' hyperpolarization. Even at the lowest dose (4 µmol/L LOV for 24 h), cellular diS-C 3 -(5) fluorescence decreased significantly (P < 0.01). The response intensified thereafter in a dose-and timedependent manner. 4 cells/ml). After treatment, cells were counted via the trypan blue method, and the cell growth inhibition was calculated. (5) for 30 min at 37ºC, and changes in the cellular membrane potential were examined using a Leica TCS NT-laser scanning confocal system. 100 cells were randomly chosen from different coverslips in each test group, and the cellular fluorescence intensity was analyzed using an image analysis system. Note: values with a different letter on a given curve differ significantly (P < 0.05). ] i were examined with a laser scanning confocal microscope. 100 cells per test group were randomly chosen, and the cellular fluorescence intensity was analyzed using an image analysis system. Note: values with a different letter on a given curve differ significantly (P < 0.05).
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The effect of LOV on intracellular Ca 2+ concentration and PMCA1 mRNA expression MCF-7 cells were treated with 4-16 µmol/L LOV for 24-72 hours and examined using laser confocal scanning microscopy. We found that the intracellular fluorescence intensity had strengthened in the test groups, indicating that the [Ca 2+ ] i had increased. Furthermore, the higher the dosage of LOV and the longer the treatment time, the more obvious the effect became (Fig. 4) , demonstrating a timeand dose-dependent relationship. RT-PCR analysis showed that PMCA1 mRNA expression in the MCF-7 cells did not change following LOV treatment (Fig. 5) , suggesting that this increase in free Ca 2+ was not due to up-regulated gene expression of calcium ATPase or elevated release of Ca 2+ from the Ca 2+ pool. It may have been due to the changed activity of calcium ATPase because of an abnormality in the membrane structure and function after LOV treatment. 
The effect of LOV on GJIC function
In the control assays, cellular LY fluorescent dye was unable to transfer to adjacent cells, instead remaining on the sides of scrape lines, which is consistent with negative GJIC function. After 24-72 hours treatment with 4, 8, or 16 µmol/L LOV, MCF-7 cells showed a time-and dose-dependent activation of GJIC to the point that the LY dye was transmitted 4-5 cell layers deep in some cases (Fig. 6 A-D, Tab. 1 ). 
Changes in the expression and activation of ERK1 and p38
MAPK
Following 48-72 h exposure to LOV, western blot analysis showed that the levels of ERK1 were unchanged (Fig. 7) . The expression of p38 MAPK was clearly down-regulated after 72 h exposure to the drug (Fig. 7) . Interestingly, the assay of kinase activation (Fig. 8) revealed that ERK1 and p38 MAPK phosphorylation levels were both markedly decreased compared to the control (P < 0.05). This was most obvious in cells treated with 16 μmol/L LOV (P < 0.01). 
DISCUSSION
Cholesterol is the main component of the cell membrane, and it plays an important role in maintaining normal membrane structure and function. An imbalance in the tightly regulated relationship between cellular sterols and other lipids can lead to membrane lipid microenvironment changes that may affect the biophysical features of the membrane, including membrane potential, membrane lipid fluidity, ion permeability and signal transmission [12] . Lovastatin (LOV), one of the drugs used to treat hyperlipidemia, can lower the level of endogenous cellular cholesterol synthesis by inhibiting the activity of HMG-CoA reductase. Recent studies have demonstrated that LOV has a potential anti-cancer property [3, 4] , but researchers have yet to reach a comprehensive understanding of the molecular mechanisms of its anti-cancer action. LOV may affect cellular proliferation and differentiation by altering the structure and function of cellular membranes and signal transmission. Membrane potential is one of the most important biophysical features of the cell membrane. DiS-C 3 -(5) [6, 7] is a lipophilic cation fluorescent dye, and it can be used to quickly and accurately assess changes in membrane potential [7, 8, [13] [14] [15] . Our experiments showed that when the exogenous LOV inhibited cholesterol synthesis and the MVA metabolic pathway, the amount of diS-C 3 - (5) fluorescence decreased in a dose-and time-dependent manner. The differences were significant at all the tested times and doses. This shows that LOV can effectively enlarge the negative value of the membrane potential of MCF-7 cells. We speculate that LOV might act by inhibiting the synthesis of cellular endogenous cholesterol, by interfering in the MVA metabolism pathway to change the cellular membrane structure and even membrane protein functions, leading to cellular hyperpolarization. Interestingly, such hyperpolarization can affect cell proliferation [16] , and many studies have demonstrated that LOV can suppress tumor cell proliferation by arresting the cell cycle in the G0/G1 phase [17, 18] . In this study, we also found that LOV inhibited MCF-7 cell proliferation and enhanced GI as time and dose increased, suggesting these effects may be closely related to the hyperpolarization of MCF-7 cells. Ca 2+ is an important signal transduction ion in cells and it plays a significant role in regulating vital cellular activities. Under normal conditions, the Ca 2+ concentration in cells is lower than that outside cells. Homeostasis of a lower Ca 2+ concentration across cellular membranes is the key to maintaining normal cellular function. Indeed, many studies have shown that increasing [Ca 2+ ] i in tumor cells is an important function of many anti-tumor drugs, as it inhibits tumor cell proliferation or initiates apoptosis [19, 20] . Thus, artificial increases in [Ca 2+ ] i in tumor cells are an important and effective mode of cancer treatment [21, 22] . In investigating LOV, an anti-cholesterol drug with possible anti-cancer applications, we found that LOV inhibited MCF-7 breast cancer cell proliferation in association with an increase in [Ca 2+ ] i . However, LOV did not affect the mRNA expression of PMCA1 [10] , which is the primary calcium pump on the membrane surface of MCF-7 cells. It is possible that LOV might change the physical properties of lipid bilayer and protein functions in the plasma membrane, thus affecting PMCA1 activities leading to the observed increase in [ GJIC plays significant roles in embryonic development, cell growth, differentiation, apoptosis, and the coordination of many other intercellular activities via the exchange of small molecules such as calcium ions, IP 3 , and cAMP between the linked cells [23] [24] [25] . The structural unit of the gap junctions is connexon, a plasma membrane protein composed of six transmembrane subunits. Research has revealed a GJIC disorder in almost all parenchymal tumor tissues, in which signal transmission was completely disrupted between adjacent tumor cells, and between tumor cells and the surrounding normal cells. In addition, varying degrees of disruption of GJIC function have been reported for cells in the process of transforming to cancer cells [26] [27] [28] , and the restoration of GJIC can suppress tumor cell growth. Many anti-cancer or chemopreventive and chemotherapeutic chemicals have been shown to either prevent the down-regulation of GJIC or up-regulate GJIC [29] . In our study, we found that while LOV inhibited MCF-7 cell proliferation, it also recovered or upregulated cellular GJIC in a dose-and time-dependent manner, suggesting a promotion of GJIC by LOV in MCF-7 cells, possibly via a change in the membrane lipid composition and membrane protein functions through the HMGCoA reductase pathway. At the same time, the MAPK pathway, another important signal system that regulates cell proliferation and cell differentiation, was affected by LOV treatment [30] [31] [32] . Our study showed that treatment with LOV did not alter the total ERK1 protein levels in MCF-7 cancer cells, but markedly inhibited ERK1 activity and p38 MAPK protein phosphorylation, as in previous findings [33] . This suggests that the MAPK signal transducing phosphorylation cascade was regulated at least partially in an MVA-dependent manner, and the influences of the drug were a consequence of its inhibitory effects on the synthesis of steroids [34] [35] . Moreover, this indicates that by changing membrane function, LOV treatment affects membrane-related MAPK cellular signal pathways, which may play a important role in inhibiting MCF-7 cell proliferation. In summary, this study demonstrates that LOV, as an inhibitor of cellular cholesterol synthesis, may change membrane lipid composition in MCF-7 cells, thereby affecting the structures and activities of ion channel proteins and gap junctional proteins in the cellular membrane. This results in the induction of cellular hyperpolarization change, intracellular calcium overload, and intercellular communications restoration. All these changes, accompanied by alterations of intracellular signal transduction and subsequent changes in the cellular metabolism, lead to the observed inhibition effect on MCF-7 breast cell proliferation.
